--- title: "Pre-market hot trades in US stocks: Fundrise Innovation Fund LLC pre-market down 8.33%; Apimeds Pharmaceuticals US pre-market down 7.99%" type: "News" locale: "en" url: "https://longbridge.com/en/news/290565938.md" description: "Fundrise Innovation Fund LLC pre-market down 8.33%; Apimeds Pharmaceuticals US pre-market down 7.99%; Atlantic pre-market up 117.94%; Boundless Bio pre-market up 76.44%; Tianci pre-market up 64.06%" datetime: "2026-06-23T12:52:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290565938.md) - [en](https://longbridge.com/en/news/290565938.md) - [zh-HK](https://longbridge.com/zh-HK/news/290565938.md) --- # Pre-market hot trades in US stocks: Fundrise Innovation Fund LLC pre-market down 8.33%; Apimeds Pharmaceuticals US pre-market down 7.99% **Pre-market Hot Trades in US Stocks** Fundrise Innovation Fund LLC is down 8.33% in pre-market trading. Based on recent key news: 1. On June 22, SpaceX's IPO attracted market attention, leading to a flow of funds towards SpaceX, which affected the performance of other space stocks. Rocket Lab's stock price fell on the day of the SpaceX IPO, as market funds shifted to SpaceX, causing fluctuations in Rocket Lab's stock price. Source: 24/7 Wall St. 2. On June 22, analysts advised investors to remain cautious due to the high volatility in the space industry. Analysts pointed out that although Rocket Lab was included in the Nasdaq 100 index, the market still needs to observe whether it can provide stable support. Source: 24/7 Wall St. 3. On June 23, global communications and AI data processing became important themes in the space industry, with investors maintaining focus on the long-term growth potential of related companies. Source: 24/7 Wall St. The space industry is highly volatile, with significant fund flows. Apimeds Pharmaceuticals US is down 7.99% in pre-market trading, with no significant news recently. Trading is active, and fund flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. **Top Gainers in Pre-market US Stocks** Atlantic is up 117.94% in pre-market trading. Based on recent key news: 1. On June 23, Atlantic International's Circle8 division won a four-year framework agreement with the Dutch Vehicle Authority, valued at approximately $52 million. The total amount of public sector contracts recently disclosed by Circle8 exceeds $430 million, including a previously announced $380 million award. This news significantly boosted investor confidence, driving the stock price sharply higher. 2. On June 22, Atlantic International announced that its Q1 revenue increased by 143% year-on-year, mainly due to the acquisition and integration of Circle8. The combined operational scale and geographic coverage have significantly expanded, with annualized revenue exceeding $1.1 billion. This strong financial performance further enhanced market optimism about the company. 3. On June 22, Atlantic International released its latest financial report through the EDGAR system, detailing the positive impact of the Circle8 acquisition on the company's operational scale and revenue. Investors are confident in the company's future growth prospects, leading to a significant increase in stock price. The ICT industry demand is strong, driven by macroeconomic recovery. Boundless Bio is up 76.44% in pre-market trading. Based on recent key news: 1. On June 23, Boundless Bio announced a merger with Serapha, and the merged company will focus on advancing gene editing therapies for Alpha-1 antitrypsin deficiency. This news drove Boundless Bio's stock price significantly higher in pre-market trading. 2. On June 23, the merger transaction secured $230 million in new funding support, providing capital and a public platform for clinical development, expected to be completed in the fourth quarter of 2026. This capital injection has enhanced market confidence in the company's future development. 3. On June 23, Boundless Bio released a press release detailing the merger terms and future development plans, further attracting investor attention and driving the stock price up. Recent capital inflows into the biotechnology sector have been significant, and risks need to be monitored. Tianci rose 64.06% in pre-market trading. Based on recent key news: 1. On June 22, Tianci International Inc. released its latest 8-K filing, detailing the company's future expectations and plans. This filing sparked optimistic sentiment in the market regarding the company's future growth, driving the stock price significantly higher. 2. On June 23, the company published original content on the EDGAR system, further enhancing investor confidence in the company's information, leading to continued stock price increases. 3. On June 23, the company issued a statement emphasizing that actual results may differ significantly from expectations, but still encouraged investors to review other factors that could impact future results. Although this statement was cautious, it did not prevent the strong rise in stock price. The market remains optimistic about the company's future growth, and trading is active ### Related Stocks - [VCX.US](https://longbridge.com/en/quote/VCX.US.md) - [APUS.US](https://longbridge.com/en/quote/APUS.US.md) - [ATLN.US](https://longbridge.com/en/quote/ATLN.US.md) - [BOLD.US](https://longbridge.com/en/quote/BOLD.US.md) - [CIIT.US](https://longbridge.com/en/quote/CIIT.US.md) ## Related News & Research - [Three prices where SpaceX stock is a buy](https://longbridge.com/en/news/294081227.md) - [Dear SpaceX Stock Fans, Mark Your Calendars for August 4](https://longbridge.com/en/news/294373599.md) - [Prediction: This is how SpaceX stock will do after Aug. 4](https://longbridge.com/en/news/293969614.md) - [SpaceX stock reaches all-time low. Here's the case for buying before Aug. 4 earnings.](https://longbridge.com/en/news/294168812.md) - [Dear SpaceX Stock Fans, Mark Your Calendars for August 6](https://longbridge.com/en/news/293852627.md)